-
COVID-19 antivirals: Access Criteria
Access criteria for molnupiravir (Lagevrio), nirmatrelvir with ritonavir (Paxlovid), and remdesivir (Veklury)
-
Sotrovimab (Xevudy) – on hold
-
Tixagevimab with cilgavimab (Evusheld) Access Criteria
-
Access criteria for treatments for persistent SARS-CoV-2 infection